No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
IM8 Vibrante Miami: Fueling Wellness and Innovation With a Star-Studded Event
Prenetics Global Limited's (NASDAQ:PRE) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Press Release: Prenetics' IM8 Health Expands Scientific Advisory Board, Reinforcing Commitment to Set New Standards in Supplements Market
Prenetics to Participate in the 37th Annual ROTH Conference
Cantor Fitzgerald Maintains Prenetics Global(PRE.US) With Buy Rating, Raises Target Price to $13
Prenetics Sees Q1 Revenue $11.5M-$13M Vs $11.2M Est.; FY25 Revenue $73M-$85M Vs $75.4M Est.